PBIO

Pressure BioSciences, Inc.

 
Common Stock
OTCQB
Contact Info
  • 14 Norfolk Avenue
  • South Easton, MA 02375


Verify Company Info
Business Description

Pressure BioSciences, Inc. (?PBI?) (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology (?PCT?). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses i...

More >>

 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2012 10-K
Regulatory Agency Financial Industry Regulatory Authority
CIK 0000830656
Fiscal Year End 12/31
OTC Market Tier OTCQB
Profile Data
SIC - Industry Classification 3826 - Analytical instruments
Business Status Development Stage Company a/o
Incorporated In: MA, USA
Year of Inc. 1978
Employees Not Available
Company Officers/Contacts
Richard Schumacher CEO
Conrad Mir CFO
Company Directors
Not Available
Company Notes
  • Formerly=Boston Biomedica, Inc. until 9-04
Service Providers
Auditor/Accountant
Marcum LLP
53 State Street, 38th Floor
Boston, MA, 02109
United States

Legal Counsel
Pepper Hamilton LLP
3000 Two Logan Square
Philadelphia, PA, 19103-2799
United States

Investor Relations Firm
Not Available
PBIO Security Details
Share Structure
Market Value1 $4,444,058 a/o May 17, 2013
Shares Outstanding 11,694,889 a/o Oct 31, 2012
Float Not Available
Authorized Shares 20,000,000 a/o Apr 25, 2012
Par Value 0.01
Shareholders
Shareholders of Record 226 a/o Apr 25, 2012
Short Selling Data
Short Interest 34,282 (-77.42%)
Apr 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Computershare Trust NA

1Market Value calculated only for respective security